Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-09-29
2000-04-04
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 12, 530324, 530325, 530326, 435 691, 930 10, 930 30, A61K 3800, A61K 3816
Patent
active
060461667
ABSTRACT:
The present invention provides peptides and peptide analogues that mimic the structural and pharmacological properties of human ApoA-I. The peptides and peptide analogues are useful to treat a variety of disorders associated with dyslipidemia.
REFERENCES:
patent: 4229360 (1980-10-01), Schneider et al.
patent: 4411894 (1983-10-01), Schrank et al.
patent: 4643998 (1987-02-01), Segrest et al.
patent: 4857319 (1989-08-01), Crowe et al.
patent: 4880635 (1989-11-01), Janoff et al.
Ngo et al. Computational Complexity, Protein Structure Prediction and Levinthal Paradox. In The protein folding and tertiary structure prediction. Eds. K.Mertz, S LeGrand, Birkhauser, London, pp. 491-499, Jan. 1984.
Anantharamaiah, 1986, Methods in Enzymology 128:627-647.
Anantharamaiah et al., 1985, J. Biol. Chem. 260:10248-10255.
Anantharamaiah et al., 1986, Proteins of Biological Fluids 34:63-66.
Anantharamaiah et al., 1990, Arteriosclerosis 10(1):95-105.
Anantharamaiah et al., 1991, Adv. Exp. Med. Biol. 285:131-140.
Badimon et al., 1990, J. Clin. Invest. 85:1234-1241.
Barrans et al., 1996, Biochim. Biophys. Acta 1300:73-85.
Beitz et al., 1992, Prostaglandins, Leukotrienes and Essential Fatty Acids 47:149-152.
Berard et al., 1997, Nature Medicine 3(7):744-749.
Blondelle et al., 1993, Biochim. Biophys. Acta 1202:331-336.
Brasseur, 1991, J. Biol. Chem. 266(24):16120-16127.
Brasseur et al., 1990, Biochim. Biophys. Acta 1043:245-252.
Brasseur et al., 1993, Biochim. Biophys. Acta 1170:1-7.
Brouilette and Anantharamaiah, 1995, Biochim. Biophys. Acta 1256:103-129.
Burkey et al., 1992, Circulation, Supplement I 86:I-472, Abstract No. 1876.
Burkey et al., 1995, J. Lipid Res. 36:1463-1473.
Cheung et al., 1991, Lipid Res.32:383-394.
Chung et al., 1985, J. Biol. Chem. 260:10256-10262.
Collet et al., 1997, Journal of Lipid Research 38:634-644.
Corijn et al., 1993, Biochim. Biophys. Acta 1170:8-16.
Davidson et al., 1994, J. Biol. Chem. 269(37):22975-22982.
Davidson et al., 1996, Proc. Natl. Acad. Sci. U.S.A. 93:13605-13610.
Deamer et al., 1983, Liposomes (Ostro, Ed.), Marcel Dekker, Inc., New York.
Demoor et al., 1996, 24th European Chemical Peptide Symposium.
Demoor et al., 1996, Eur. J. Biochem. 239:74-84.
Dufourcq et al., 1986, Biochim. Biohys. Acta 859:33-48.
Duverger, 1996, Circulation 94:713-717.
Duverger et al., 1996, Arterioscler. Thromb. Vasc. Biol. 16:1424-1429.
Emmanuel et al., 1994, J. Biol. Chem. 269(47):29883-29890.
Epand et al., 1987, J. Biol. Chem. 262:9389-9396.
Epand et al., 1995, Biopolymers (Peptide Science) 37:319-338.
Esposito et al., 1997, Biopolymers 41:27-35.
Fielding and Fielding, 1995, J. Lipid Res. 36:211-228.
Fournier et al., 1996, J. Lipid Res. 37:1704-1711.
Francone et al., 1995, J. Clinic. Invet. 96:1440-1448.
Frank et al., 1997, Biochemistry 36:1789-1806.
Fruchart and Ailhaud, 1992, Clin. Chem. 38:793-797.
Fukushima et al., 1979, J. Am. Chem. Soc. 101(13):3703-3704.
Fukushima et al., 1980, J. Biol. Chem. 255:10651-10657.
Garber et al., 1992, Arteriosclerosis and Thrombosis 12:886-894.
Gordon et al., 1989, Circulation 79:8-15.
Gordon and Rifkind, 1989, N. Eng. J. Med. 321:1311-1316.
Groebke et al., 1996, Proc. Natl. Acad. Sci. U.S.A. 93:4025-4029.
Hirano et al., 1997, Arterioscler. Thromb. Vasc. Biol. 17(6):1053-1059.
Holvoet et al., 1995, Biochemistry 34:13334-13342.
Hope et al., 1986, Chemistry and Physics of Lipids 40:89-107.
Huyghues-Despointes et al., 1995, Biochemistry 34(41):13267-13271.
Ji and Jonas, 1995, J. Biol. Chem. 270:11290-11297.
Johnson et al., 1971, Biochim. Biophys. Acta 233:820.
Jonas, 1986, Methods in Enzymol. 128:553-582.
Jonas, 1992, "Lipid-Binding Properties of Apolipoproteins," In: Structure and Function of Apolipoproteins, CRC Press, Ch. 8, pp. 217-250.
Kaiser, 1970, Anal. Biochem. 34:595-598.
Kaiser and Kezdy, 1983, Proc. Natl. Acad. Sci. U.S.A. 80:1137-1143.
Kannelis et al., 1980J. Biol. Chem. 255(3):11464-11472.
Koizumi et al., 1988, J. Lipid Res. 29:1405-1415.
Kneib-Cordonnier et al., 1990, Int. J. Peptide Protein Res. 35:527-538.
Knott et al., 1985, Science 230:37-43.
Labeur et al., 1997, Arterioscler. Throm. Vasc. Biol. 17:580-588.
Lacko and Miller, 1997, J. Lip. Res. 38:1267-1273.
Li et al., 1996, Proc. Natl. Acad. Sci. U.S.A. 93:6676-6681.
Lins et al., 1993, Biochim. Biophys. Acta Biomembranes 1151:137-142.
Liu et al., 1994, J. Lipid Res. 35:2263-2267.
Livingstone, 1974, Methods in Enzymology: Immunoaffinity Chromatography of Proteins 34:723-731.
Lund-Katz et al., 1990, J. Biol. Chem. 265(21):12217-12223.
Lund-Katz et al., 1995, Biochemistry 34:9219-9226.
Marqusee et al., 1987, Proc. Natl. Acad. Sci. U.S.A. 84(24):8898-8902.
Mendez et al., 1994, J. Clin. Invest. 94:1698-1705.
Mezdour et al., 1995, Atherosclerosis 113:237-246.
Miller, 1987, Amer. Heart 113:589-597.
Milner-White and Poet, 1987, Trends Biochem. Sci. 12:189-192.
Minnich et al., 1992, J. Biol. Chem. 267:16553-16560.
Mishra et al., 1994, J. Biol. Chem. 269(10):7185-7191.
Mishra et al., 1995, J. Biol. Chem. 270(4):1602-1611.
Nakagawa et al., 1985, J. Am. Chem. Soc. 107:7087-7092.
Nedelec et al., 1989, Biochimie 71:145-151.
Palgunachari et al., 1996, Arterioscler. Thromb. Vasc. Biol. 16:328-338.
Paszty et al., 1994, J. Clin. Invest. 94:899-903.
Plump et al., 1994, Proc. Natl. Acad. Sci. U.S.A. 91:9607-9611.
Ponsin et al., 1984, Biochemistry 23:5337-5342.
Ponsin et al., 1986, J. Biol. Chem. 261(20):9202-9205.
Pownall et al., 1980, Proc. Natl. Acad. Sci. U.S.A. 77(6):3154-3158.
Rogers et al., 1997, Biochemistry 36:288-300.
Rosseneu et al., In: Structure and Function of the Lipoproteins, Ch. 6, 159-183, CRC Press, Inc., 1992.
Rosseneu and Labeur, 1995, FASEB J. 9:768-776.
Rubin et al., 1991, Nature 353:265-267.
Schnolzer and Kent, 1992, Science 256:221-225.
Schultz et al., 1993, Nature 365:762-764.
Segrest, 1974, FEBS Lett. 38:247-253.
Segrest, 1976, FEBS Lett. 69(1):111-114.
Segrest et al., 1983, J. Biol. Chem. 258:2290-2295.
Segrest et al., 1990, Proteins: Structure, Function and Genetics 8:103-117.
Segrest et al., 1994, Advances in Protein Chemistry 45:303-369.
Sorci-Thomas et al., 1993, J. Biol. Chem. 268:21403-21409.
Sorci-Thomas et al., 1997, J. Biol. Chem. 272(11):7278-7284.
Sparks et al., 1995, J. Biol. Chem. 270(10):5151-5157.
Sparrow and Gotto, 1980, Ann. N.Y. Acad. Sci. 348:187-211.
Sparrow and Gotto, 1982, CRC Crit. Rev. Biochem. 13:87-107.
Sparrow and Gotto, Ch. 10: "Lipid-Protein Interactions: Structure-Function Relationships".
Sparrow et al., 1981, In: "Peptides: Synthesis-Structure-Function," Roch and Gross, Eds., Pierce Chem. Co., Rockford, IL, 253-256.
Spuhler et al., 1994, J. Biol. Chem. 269(39):23904-23910.
Subbarao et al., 1988, Proteins: Structure, Function and Genetics 3:187-198.
Tam, 1988, Proc. Natl. Acad. Sci. U.S.A. 85:5409-5413.
Tytler et al., 1993, J. Biol. Chem. 268(29):22112-22118.
Vanloo et al., 1992, Biochim. Biophys. Acta 1128:258-266.
Venkatachalapathi et al., 1991, Mol. Conformation and Biol. Interactions, Indian Acad. Sci. B:585-596.
Venkatachalapathi et al., 1993, Proteins: Structure, Function and Genetics 15:349-359.
Wang et al., 1996, Biochim. Biophys. Acta 1301:174-184.
Wilmot and Thornton, 1988, J. Mol. Biol. 203:221-232.
Yancey et al., 1995, Biochemistry 34:7955-7965.
Yokoyama et al., 1980, J. Biol. Chem. 255(15):7333-7339.
Buttner Klaus
Cornut Isabelle
Dasseux Jean-Louis
Metz Gunther
Sekul Renate
Borin Michael
Buttner Klaus
Cornut Isabelle
Dasseux Jean-Louis
DuFourcq Jean
LandOfFree
Apolipoprotein A-I agonists and their use to treat dyslipidemic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Apolipoprotein A-I agonists and their use to treat dyslipidemic , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apolipoprotein A-I agonists and their use to treat dyslipidemic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-365072